{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:58:30Z","timestamp":1773514710330,"version":"3.50.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>The prognostic impact of hyperuricemia and the factors that induce hyperuricemia in cardiovascular intensive care patients remain unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results:<\/jats:title>\n                  <jats:p>A total of 3257 emergency department patients were screened, and data for 2435 patients who were admitted to an intensive care unit were analyzed. The serum uric acid level was measured within 15 min of admission. The patients were assigned to a low-uric acid group (uric acid \u2a7d7.0 mg\/dl, n=1595) or a high-uric acid group (uric acid &amp;gt;7.0 mg\/dl, n=840) according to their uric acid level on admission. Thereafter, the patients were divided into four groups according to the quartiles of their serum uric acid level (Q1, Q2, Q3 and Q4), and uric acid levels and Acute Physiology and Chronic Health Evaluation II (APACHE II) score. A Kaplan\u2013Meier curve showed a significantly lower 365-day survival rate in a high-uric acid group than in a low-uric acid group, and in Q3 than in Q1 or Q2 and in Q4 than in the other groups. The multivariate logistic regression model for 30-day mortality identified Q4 (odds ratio: 1.856, 95% confidence interval (CI) 1.140\u20133.022; p=0.013) as an independent predictor of 30-day mortality. The area under the receiver-operating characteristic curve values of the serum uric acid level and APACHE II score for the prediction of 30-day mortality were 0.648 and 0.800, respectively. The category-free net reclassification improvement and integrated discrimination improvement showed that the calculated risk shifted to the correct direction by adding the serum uric acid level to the APACHE II score (0.204, 95% CI 0.065\u20130.344; p=0.004, and 0.015, 95% CI 0.005\u20130.025; p=0.004, respectively). The prognosis, including the 365-day mortality, among patients with a high uric acid level and a high APACHE II score was significantly poorer in comparison with other patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>The serum uric acid level, which might be elevated by the various critical stimuli on admission, was an independent predictor in patients who were emergently hospitalized in the intensive care unit. The serum uric acid level is therefore useful as a surrogate biomarker for critical patients in the intensive care unit.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1177\/2048872618822473","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T13:42:59Z","timestamp":1547732579000},"page":"636-648","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["The prognostic impact of the uric acid level in patients who require cardiovascular intensive care \u2013 is serum uric acid a surrogate biomarker for critical patients in the non-surgical intensive care unit?"],"prefix":"10.1093","volume":"9","author":[{"given":"Yusaku","family":"Shibata","sequence":"first","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Shirakabe","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotake","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Sawatani","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tani","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan"},{"name":"Center for Clinical Research, Nippon Medical School Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritake","family":"Hata","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniya","family":"Asai","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"2021020117071801700_bibr1-2048872618822473","doi-asserted-by":"crossref","first-page":"e114259","DOI":"10.1371\/journal.pone.0114259","article-title":"Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2021020117071801700_bibr2-2048872618822473","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/1440-1681.12911","article-title":"Hyperuricaemia and development of type 2 diabetes mellitus in Asian population","volume":"45","author":"Choi","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2021020117071801700_bibr3-2048872618822473","doi-asserted-by":"crossref","first-page":"852954","DOI":"10.1155\/2014\/852954","article-title":"Review of hyperuricemia as new marker for metabolic syndrome","volume":"2014","author":"Billiet","year":"2014","journal-title":"ISRN Rheumatol"},{"key":"2021020117071801700_bibr4-2048872618822473","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0003319711423806","article-title":"Serum uric acid: A marker of metabolic syndrome and subclinical atherosclerosis in Korean men","volume":"63","author":"Zhang","year":"2012","journal-title":"Angiology"},{"key":"2021020117071801700_bibr5-2048872618822473","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar3322","article-title":"Hyperuricemia and the risk for subclinical coronary atherosclerosis \u2013 data from a prospective observational cohort study","volume":"13","author":"Krishnan","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021020117071801700_bibr6-2048872618822473","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2006.04.016","article-title":"Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals","volume":"192","author":"Ishizaka","year":"2007","journal-title":"Atherosclerosis"},{"key":"2021020117071801700_bibr7-2048872618822473","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jjcc.2016.04.013","article-title":"The prognostic impact of uric acid in patients with severely decompensated acute heart failure","volume":"68","author":"Okazaki","year":"2016","journal-title":"J Cardiol"},{"key":"2021020117071801700_bibr8-2048872618822473","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00380-016-0893-z","article-title":"Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia","volume":"32","author":"Okazaki","year":"2017","journal-title":"Heart Vessels"},{"key":"2021020117071801700_bibr9-2048872618822473","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2016.11.077","article-title":"Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure","volume":"228","author":"Otaki","year":"2017","journal-title":"Int J Cardiol"},{"key":"2021020117071801700_bibr10-2048872618822473","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.metabol.2017.01.031","article-title":"Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans","volume":"70","author":"Washio","year":"2017","journal-title":"Metabolism"},{"key":"2021020117071801700_bibr11-2048872618822473","doi-asserted-by":"crossref","first-page":"e0182699","DOI":"10.1371\/journal.pone.0182699","article-title":"Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients","volume":"12","author":"Fujimura","year":"2017","journal-title":"PLoS One"},{"key":"2021020117071801700_bibr12-2048872618822473","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","article-title":"Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications","volume":"555","author":"Berry","year":"2004","journal-title":"J Physiol"},{"key":"2021020117071801700_bibr13-2048872618822473","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.7754\/Clin.Lab.2018.180334","article-title":"The association between serum uric acid level and prognosis in critically ill patients, uric acid as a prognosis predictor","volume":"64","author":"Pehlivanlar-Kucuk","year":"2018","journal-title":"Clin Lab"},{"key":"2021020117071801700_bibr14-2048872618822473","first-page":"324","article-title":"Essence of the revised guideline for the management of hyperuricemia and gout","volume":"55","author":"Yamanaka","year":"2012","journal-title":"Japan Med Assoc J"},{"key":"2021020117071801700_bibr15-2048872618822473","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"2021020117071801700_bibr16-2048872618822473","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/1871530318666180212101548","article-title":"Uric acid, metabolic syndrome and atherosclerosis: The chicken or the egg, which comes first?","volume":"18","author":"De Pergola","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2021020117071801700_bibr17-2048872618822473","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3899\/jrheum.081199","article-title":"Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate","volume":"36","author":"See","year":"2009","journal-title":"J Rheumatol"},{"key":"2021020117071801700_bibr18-2048872618822473","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","article-title":"Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: Second edition","volume":"30","author":"Yamanaka","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2021020117071801700_bibr19-2048872618822473","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/nep.12411","article-title":"Impact of hyperuricaemia on the chronic kidney disease-associated risk factors in a community-based population","volume":"20","author":"Tsumuraya","year":"2015","journal-title":"Nephrology"},{"key":"2021020117071801700_bibr20-2048872618822473","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"2021020117071801700_bibr21-2048872618822473","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjcard.2018.03.022","article-title":"Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to serum uric acid levels in patients with acute coronary syndrome","volume":"122","author":"Kobayashi","year":"2018","journal-title":"Am J Cardiol"},{"key":"2021020117071801700_bibr22-2048872618822473","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ahj.2017.02.023","article-title":"An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome","volume":"187","author":"Pagidipati","year":"2017","journal-title":"Am Heart J"},{"key":"2021020117071801700_bibr23-2048872618822473","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/07388551.2010.527823","article-title":"Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction coupling","volume":"31","author":"Agarwal","year":"2011","journal-title":"Crit Rev Biotechnol"},{"key":"2021020117071801700_bibr24-2048872618822473","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12253-013-9698-x","article-title":"Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review","volume":"20","author":"Robert","year":"2014","journal-title":"Pathol Oncol Res"}],"container-title":["European Heart Journal. Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2048872618822473","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2048872618822473","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/6\/636\/36165983\/ehjacc0636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/6\/636\/36165983\/ehjacc0636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:19:24Z","timestamp":1618877964000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/9\/6\/636-648\/6125608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,9,1]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2048872618822473","relation":{},"ISSN":["2048-8734","2048-8726"],"issn-type":[{"value":"2048-8734","type":"electronic"},{"value":"2048-8726","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,9,1]]},"published":{"date-parts":[[2020,9,1]]}}}